Skip to main content
Top
Published in: European Journal of Epidemiology 11/2018

Open Access 01-11-2018 | META-ANALYSIS

Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies

Authors: Dagfinn Aune, Yahya Mahamat-Saleh, Teresa Norat, Elio Riboli

Published in: European Journal of Epidemiology | Issue 11/2018

Login to get access

Abstract

We conducted a systematic review and meta-analysis to clarify the association between adiposity, diabetes, and physical activity and the risk of kidney stones. PubMed and Embase were searched up to April 22nd 2018 for relevant studies. Summary relative risks (RRs) and 95% confidence intervals (CIs) were calculated using random effects models. Thirteen cohort studies were included. The summary relative risk was 1.21 (95% CI 1.12–1.30, I2 = 76%, n = 8) per 5 unit increment in BMI, 1.16 (95% CI 1.12–1.19, I2 = 0%, n = 5) per 10 cm increase in waist circumference, 1.06 (95% CI 1.04–1.08, I2 = 67%, n = 3) per 5 kg increase in weight and 1.12 (95% CI 1.06–1.18, I2 = 86%, n = 3) per 5 kg of weight gain. The summary RR was 1.16 (95% CI 1.03–1.31, I2 = 51%, n = 10) for participants with diabetes compared to participants without diabetes, and 0.93 (95% CI 0.78–1.10, I2 = 80%, n = 4) for high vs. low physical activity. These results suggest a positive association between adiposity and diabetes and the risk of kidney stones, but no association with physical activity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86–96.PubMedPubMedCentral Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86–96.PubMedPubMedCentral
2.
go back to reference Johnson CM, Wilson DM, O’Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979;16:624–31.CrossRef Johnson CM, Wilson DM, O’Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979;16:624–31.CrossRef
3.
go back to reference Lingeman JE, Saywell RM Jr, Woods JR, Newman DM. Cost analysis of extracorporeal shock wave lithotripsy relative to other surgical and nonsurgical treatment alternatives for urolithiasis. Med Care. 1986;24:1151–60.CrossRef Lingeman JE, Saywell RM Jr, Woods JR, Newman DM. Cost analysis of extracorporeal shock wave lithotripsy relative to other surgical and nonsurgical treatment alternatives for urolithiasis. Med Care. 1986;24:1151–60.CrossRef
4.
go back to reference Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13(Suppl 3):S45–50.PubMed Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13(Suppl 3):S45–50.PubMed
5.
go back to reference Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O, Palsson R. Temporal trends in the incidence of kidney stone disease. Kidney Int. 2013;83:146–52.CrossRef Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O, Palsson R. Temporal trends in the incidence of kidney stone disease. Kidney Int. 2013;83:146–52.CrossRef
6.
go back to reference Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817–23.CrossRef Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817–23.CrossRef
7.
go back to reference Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE. Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol. 2014;29:363–9.CrossRef Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE. Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol. 2014;29:363–9.CrossRef
8.
go back to reference Ahmed MH, Ahmed HT, Khalil AA. Renal stone disease and obesity: what is important for urologists and nephrologists? Ren Fail. 2012;34:1348–54.CrossRef Ahmed MH, Ahmed HT, Khalil AA. Renal stone disease and obesity: what is important for urologists and nephrologists? Ren Fail. 2012;34:1348–54.CrossRef
9.
go back to reference Cheungpasitporn W, Thongprayoon C, O’Corragain OA, et al. The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM. 2015;108:205–12.CrossRef Cheungpasitporn W, Thongprayoon C, O’Corragain OA, et al. The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM. 2015;108:205–12.CrossRef
10.
go back to reference Shang W, Li L, Ren Y, et al. History of kidney stones and risk of chronic kidney disease: a meta-analysis. PeerJ. 2017;5:e2907.CrossRef Shang W, Li L, Ren Y, et al. History of kidney stones and risk of chronic kidney disease: a meta-analysis. PeerJ. 2017;5:e2907.CrossRef
11.
go back to reference Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract. 2010;11:49.CrossRef Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract. 2010;11:49.CrossRef
12.
go back to reference Ferraro PM, Taylor EN, Eisner BH, et al. History of kidney stones and the risk of coronary heart disease. JAMA. 2013;310:408–15.CrossRef Ferraro PM, Taylor EN, Eisner BH, et al. History of kidney stones and the risk of coronary heart disease. JAMA. 2013;310:408–15.CrossRef
13.
go back to reference Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455–62.CrossRef Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455–62.CrossRef
14.
go back to reference Sorensen MD, Chi T, Shara NM, et al. Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women’s Health Initiative. J Am Soc Nephrol. 2014;25:362–9.CrossRef Sorensen MD, Chi T, Shara NM, et al. Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women’s Health Initiative. J Am Soc Nephrol. 2014;25:362–9.CrossRef
15.
go back to reference Yoshimura E, Sawada SS, Lee IM, et al. Body mass index and kidney stones: a cohort study of Japanese men. J Epidemiol. 2016;26:131–6.CrossRef Yoshimura E, Sawada SS, Lee IM, et al. Body mass index and kidney stones: a cohort study of Japanese men. J Epidemiol. 2016;26:131–6.CrossRef
16.
go back to reference Oda E. Overweight and high-sensitivity C-reactive protein are weakly associated with kidney stone formation in Japanese men. Int J Urol. 2014;21:1005–11.CrossRef Oda E. Overweight and high-sensitivity C-reactive protein are weakly associated with kidney stone formation in Japanese men. Int J Urol. 2014;21:1005–11.CrossRef
17.
go back to reference Akoudad S, Szklo M, McAdams MA, et al. Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study. Prev Med. 2010;51:416–20.CrossRef Akoudad S, Szklo M, McAdams MA, et al. Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study. Prev Med. 2010;51:416–20.CrossRef
18.
go back to reference Ando R, Suzuki S, Nagaya T, et al. Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol. 2011;18:131–8.CrossRef Ando R, Suzuki S, Nagaya T, et al. Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol. 2011;18:131–8.CrossRef
19.
go back to reference Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230–5.CrossRef Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230–5.CrossRef
20.
go back to reference Landgren AJ, Jacobsson LTH, Lindstrom U, et al. Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study. Arthritis Res Ther. 2017;19:173.CrossRef Landgren AJ, Jacobsson LTH, Lindstrom U, et al. Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study. Arthritis Res Ther. 2017;19:173.CrossRef
21.
go back to reference Jakobsen AK, Jacobsson LT, Patschan O, Askling J, Kristensen LE. Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects. PLoS ONE. 2014;9:e113602.CrossRef Jakobsen AK, Jacobsson LT, Patschan O, Askling J, Kristensen LE. Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects. PLoS ONE. 2014;9:e113602.CrossRef
22.
go back to reference Masterson JH, Woo JR, Chang DC, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis. 2015;43:49–53.CrossRef Masterson JH, Woo JR, Chang DC, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis. 2015;43:49–53.CrossRef
23.
go back to reference Shih MT, Tang SH, Cha TL, Wu ST, Chiang JH, Chen WC. The risk of nephrolithiasis among patients with ankylosing spondylitis: a population-based cohort study. Arch Rheumatol. 2016;31(4):346–52.CrossRef Shih MT, Tang SH, Cha TL, Wu ST, Chiang JH, Chen WC. The risk of nephrolithiasis among patients with ankylosing spondylitis: a population-based cohort study. Arch Rheumatol. 2016;31(4):346–52.CrossRef
24.
go back to reference Shu X, Cai H, Xiang YB, et al. Nephrolithiasis among middle aged and elderly urban Chinese: a report from prospective cohort studies in Shanghai. J Endourol. 2017;31:1327–34.CrossRef Shu X, Cai H, Xiang YB, et al. Nephrolithiasis among middle aged and elderly urban Chinese: a report from prospective cohort studies in Shanghai. J Endourol. 2017;31:1327–34.CrossRef
25.
go back to reference Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392–404.CrossRef Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392–404.CrossRef
26.
go back to reference Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Epidemiol. 2015;30:529–42.CrossRef Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Epidemiol. 2015;30:529–42.CrossRef
27.
go back to reference Ferraro PM, Curhan GC, Sorensen MD, Gambaro G, Taylor EN. Physical activity, energy intake and the risk of incident kidney stones. J Urol. 2015;193:864–8.CrossRef Ferraro PM, Curhan GC, Sorensen MD, Gambaro G, Taylor EN. Physical activity, energy intake and the risk of incident kidney stones. J Urol. 2015;193:864–8.CrossRef
28.
go back to reference Wu CC, Hung SH, Lin HC, Lee CZ, Lee HC, Chung SD. Sialolithiasis is associated with nephrolithiasis: a case-control study. Acta Otolaryngol. 2016;136:497–500.CrossRef Wu CC, Hung SH, Lin HC, Lee CZ, Lee HC, Chung SD. Sialolithiasis is associated with nephrolithiasis: a case-control study. Acta Otolaryngol. 2016;136:497–500.CrossRef
29.
go back to reference Zhao A, Dai M, Chen YJ, Chang HE, Liu AP, Wang PY. Risk factors associated with nephrolithiasis: a case-control study in China. Asia Pac J Public Health. 2015;27:NP414–24.CrossRef Zhao A, Dai M, Chen YJ, Chang HE, Liu AP, Wang PY. Risk factors associated with nephrolithiasis: a case-control study in China. Asia Pac J Public Health. 2015;27:NP414–24.CrossRef
30.
go back to reference Akarken I, Tarhan H, Ekin RG, et al. Visceral obesity: a new risk factor for stone disease. Can Urol Assoc J. 2015;9:E795–9.CrossRef Akarken I, Tarhan H, Ekin RG, et al. Visceral obesity: a new risk factor for stone disease. Can Urol Assoc J. 2015;9:E795–9.CrossRef
31.
go back to reference Nerli R, Jali M, Guntaka AK, Patne P, Patil S, Hiremath MB. Type 2 diabetes mellitus and renal stones. Adv Biomed Res. 2015;4:180.PubMedPubMedCentral Nerli R, Jali M, Guntaka AK, Patne P, Patil S, Hiremath MB. Type 2 diabetes mellitus and renal stones. Adv Biomed Res. 2015;4:180.PubMedPubMedCentral
32.
go back to reference Milicevic S, Bijelic R, Krivokuca V, Bojic M, Popovic-Pejicic S, Bojanic N. Correlation of the body mass index and calcium nephrolithiasis in adult population. Med Arch. 2013;67:423–7.CrossRef Milicevic S, Bijelic R, Krivokuca V, Bojic M, Popovic-Pejicic S, Bojanic N. Correlation of the body mass index and calcium nephrolithiasis in adult population. Med Arch. 2013;67:423–7.CrossRef
33.
go back to reference Lieske JC, de la Vega LS, Gettman MT, et al. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis. 2006;48:897–904.CrossRef Lieske JC, de la Vega LS, Gettman MT, et al. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis. 2006;48:897–904.CrossRef
34.
go back to reference Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S. Kidney stone disease and risk factors for coronary heart disease. Int J Urol. 2005;12:859–63.CrossRef Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S. Kidney stone disease and risk factors for coronary heart disease. Int J Urol. 2005;12:859–63.CrossRef
35.
go back to reference Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.CrossRef Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.CrossRef
36.
go back to reference DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRef DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRef
37.
go back to reference Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–9.CrossRef Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–9.CrossRef
38.
go back to reference Bagnardi V, Zambon A, Quatto P, Corrao G. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol. 2004;159:1077–86.CrossRef Bagnardi V, Zambon A, Quatto P, Corrao G. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol. 2004;159:1077–86.CrossRef
39.
go back to reference Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRef Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRef
40.
go back to reference Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.CrossRef Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.CrossRef
41.
go back to reference Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.CrossRef Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.CrossRef
43.
go back to reference NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–42.CrossRef NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–42.CrossRef
44.
go back to reference NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513–30.CrossRef NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513–30.CrossRef
45.
go back to reference Aune D, Norat T, Vatten LJ. Body mass index and the risk of gout: a systematic review and dose-response meta-analysis of prospective studies. Eur J Nutr. 2014;53:1591–601.CrossRef Aune D, Norat T, Vatten LJ. Body mass index and the risk of gout: a systematic review and dose-response meta-analysis of prospective studies. Eur J Nutr. 2014;53:1591–601.CrossRef
46.
go back to reference Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–15.CrossRef Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–15.CrossRef
47.
go back to reference Aune D, Norat T, Vatten LJ. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol. 2015;30:1009–19.CrossRef Aune D, Norat T, Vatten LJ. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol. 2015;30:1009–19.CrossRef
48.
go back to reference Abdullah A, Peeters A, de Court M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 2010;89:309–19.CrossRef Abdullah A, Peeters A, de Court M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 2010;89:309–19.CrossRef
49.
go back to reference Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolithiasis in men: the Health Professionals’ Follow-Up Study. Kidney Int. 2003;64:1022–6.CrossRef Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolithiasis in men: the Health Professionals’ Follow-Up Study. Kidney Int. 2003;64:1022–6.CrossRef
50.
go back to reference Kim S, Chang Y, Yun KE, et al. Development of nephrolithiasis in asymptomatic hyperuricemia: a cohort study. Am J Kidney Dis. 2017;70:173–81.CrossRef Kim S, Chang Y, Yun KE, et al. Development of nephrolithiasis in asymptomatic hyperuricemia: a cohort study. Am J Kidney Dis. 2017;70:173–81.CrossRef
51.
go back to reference Taylor EN, Chan AT, Giovannucci EL, Curhan GC. Cholelithiasis and the risk of nephrolithiasis. J Urol. 2011;186:1882–7.CrossRef Taylor EN, Chan AT, Giovannucci EL, Curhan GC. Cholelithiasis and the risk of nephrolithiasis. J Urol. 2011;186:1882–7.CrossRef
52.
go back to reference DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. 1975;55:845–55.CrossRef DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. 1975;55:845–55.CrossRef
53.
go back to reference Mandel EI, Taylor EN, Curhan GC. Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion. Clin J Am Soc Nephrol. 2013;8:901–8.CrossRef Mandel EI, Taylor EN, Curhan GC. Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion. Clin J Am Soc Nephrol. 2013;8:901–8.CrossRef
54.
go back to reference Sasaki Y, Kohjimoto Y, Iba A, Matsumura N, Hara I. Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome. Int J Urol. 2015;22:404–9.CrossRef Sasaki Y, Kohjimoto Y, Iba A, Matsumura N, Hara I. Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome. Int J Urol. 2015;22:404–9.CrossRef
Metadata
Title
Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies
Authors
Dagfinn Aune
Yahya Mahamat-Saleh
Teresa Norat
Elio Riboli
Publication date
01-11-2018
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 11/2018
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-018-0426-4

Other articles of this Issue 11/2018

European Journal of Epidemiology 11/2018 Go to the issue